Medicare Enrolled

Dr. Madhurima Uppalapati, MD

Hematology & Oncology · Marietta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
340 KENNESTONE HOSPITAL BLVD STE 100, Marietta, GA 30060
7702815100
Registered in NPPES since 2006
NPI: 1497711931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Uppalapati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Uppalapati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Uppalapati

Dr. Madhurima Uppalapati is a hematology & oncology specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Uppalapati performed 543 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Uppalapati received a total of $4,318 from 40 pharmaceutical and/or device companies across 154 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Uppalapati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 543 Medicare services $4,318 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
543
Medicare services
Bottom 35% in GA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
278 $69 $282
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
124 $109 $386
New patient office visit, complex (60-74 min) 47 $142 $484
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $49 $198
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $107 $375
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
25 $78 $269
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,318
Total received (2018-2024)
Avg $617/year across 7 years
Top 46% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
154
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,195
2023
$368
2022
$346
2021
$108
2020
$66
2019
$509
2018
$726

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$1,231
ABBVIE INC.
$188
Bayer Healthcare Pharmaceuticals Inc.
$106
AstraZeneca Pharmaceuticals LP
$103
Janssen Biotech, Inc.
$96
PFIZER INC.
$93
Daiichi Sankyo Inc.
$91
SOBI, INC
$65
Alexion Pharmaceuticals, Inc.
$44
Karyopharm Therapeutics Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
Celgene Corporation
$26
GENZYME CORPORATION
$24
Stemline Therapeutics Inc.
$20
Eisai Inc.
$19
Exelixis Inc.
$18
Deciphera Pharmaceuticals Inc.
$15
Top 3 companies account for 69.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,546
Janssen Biotech, Inc.
$242
PFIZER INC.
$219
E.R. Squibb & Sons, L.L.C.
$198
ABBVIE INC.
$188
Genentech USA, Inc.
$171
Seagen Inc.
$163
Daiichi Sankyo Inc.
$130
AstraZeneca Pharmaceuticals LP
$117
Amgen Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$106
Ipsen Biopharmaceuticals, Inc
$103
Astellas Pharma US Inc
$100
EISAI INC.
$91
Celgene Corporation
$83
SOBI, INC
$65
Pharmacyclics LLC, an AbbVie Company
$52
Seattle Genetics, Inc.
$47
Alexion Pharmaceuticals, Inc.
$44
TerSera Therapeutics LLC
$43
JAZZ PHARMACEUTICALS INC.
$42
Exelixis Inc.
$39
TESARO, Inc.
$39
Stemline Therapeutics Inc.
$39
GENZYME CORPORATION
$38
Merck Sharp & Dohme Corporation
$34
Karyopharm Therapeutics Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
Blueprint Medicines Corporation
$21
Rigel Pharmaceuticals, Inc.
$20
Eisai Inc.
$19
Pharmacyclics LLC, An AbbVie Company
$18
Sun Pharmaceutical Industries Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
Deciphera Pharmaceuticals Inc.
$15
Lilly USA, LLC
$15
TOLMAR Pharmaceuticals, Inc.
$14
Foundation Medicine, Inc.
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALOXI · AYVAKIT · Avastin · BAVENCIO · BRAFTOVI · CABLIVI · CABOMETYX · Cabometyx · DARZALEX · DOPTELET · ELIGARD · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Erleada · FOUNDATIONONE · FRUZAQLA · GAZYVA · Herceptin · IBRANCE · IMBRUVICA · INJECTAFER · Imbruvica · Inrebic · JEVTANA · KEYTRUDA · KISQALI · Kerendia · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MVASI · Neulasta · Nplate · Nubeqa · OPDIVO · Orserdu · PIQRAY · PROMACTA · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · SOMATULINE DEPOT · TAGRISSO · TUKYSA · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · XPOVIO · XTANDI · Xermelo · YONSA · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Marietta?
Compare hematology & oncology specialists in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
156
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Uppalapati is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Uppalapati experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Uppalapati performed 278 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Uppalapati receive payments from pharmaceutical companies?
Yes. Dr. Uppalapati received a total of $4,318 from 40 companies across 154 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Uppalapati's costs compare to other hematology & oncology specialists in Marietta?
Dr. Uppalapati's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Uppalapati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →